C-terminal cross-linking telopeptide levels in COVID-19 patients: A prospective case-control study
Description
CONCLUSIONS: Increased serum CTX-I levels in the patient group caused COVID-19-driven bone degradation, though serum CTX-I levels did not differ according to disease severity.
